[#item_full_content] Full-year revenue grew 8% to CAD 45.1 million, led by international medical cannabis, with gross margin at 31% and improved profitability. The company ended 2025 with CAD 10.8 million in cash, virtually no debt, and a focus on expanding in regulated global markets.Based on MediPharm Labs Corp. [LAB…  Read More